Overview

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Status:
COMPLETED
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-1" and "BR1019-2" in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd